Ivan Horvath MF2 Renal
Activity
Tutorial
Tutorial
Ivan Horvath is a 70-year-old male with hypertension which first developed in his late 40s/early 50s and has slowly worsened over time. He also has dyslipidemia and obesity. He has a 60 pack-year history of smoking. He has recently moved and you see him with his new family physician. He currently takes amlodipine (calcium channel blocker) and chlorthalidone (thiazide diuretic) for his hypertension. Physical examination shows BP of 178/88 mm Hg, silver wiring of the retinal vessels, no edema, and S4 on heart auscultation.
Curriculum Block
Medical Foundation 2 / Part 2 / Renal / Week 2
- Indicates most relevant
Objectives
General Objectives
- Explain the structure, function and physiology of the urinary tract, kidney, nephron and glomerulus
- Explain the possible underlying mechanisms of edema, hypertension, oliguria and renal insufficiency and apply them to clinical presentations.
- Explain the nephrotoxic potential of certain drugs.
- Describe the role of renal blood flow, capillary hydrostatic pressure and capillary.
- Explain the mechanisms responsible for maintaining blood pressure in the normal range.
- Explain the pathological consequences of hypertension on the brain, heart and kidneys.
- Explain the mechanisms responsible for essential and secondary hypertension.
- Explain the mechanisms of action by which diuretics, beta blockers, ACE inhibitors, ARBs, and calcium channel blockers reduce elevated blood pressure.
- Explain the structure, function and physiology of the urinary tract, kidney, nephron and glomerulus
Global Objectives
Assessments
End-Unit Tutorial Assessment
Mid-Unit Tutorial Assessment
Concept Application Exercise (CAE)
Tags
Basic Sciences
Biochemistry
Histology
Pathology
Pharmacology
Curriculum Block
Medical Foundation 2
Part 2
Renal
Week 2
Curriculum Week
Part 2
Week 2
Discipline
Family medicine
Geriatrics
Nephrology
Pharmacology
MCC Presentations
Generalized Edema
Hypertension
McMaster Program Competencies
1.3 Interpret laboratory data, imaging studies, and other tests required for the area of practice
2.2 Apply biomedical scientific principles fundamental to health care for patients and populations.
3.6 Locate, appraise, and incorporate evidence from research related to patients’ health problems and the provision of healthcare
3.8 Obtain and use information about individual patients and their caregivers, populations of patients, or communities with which patients identify to improve care
MeSH
Angiotensin-Converting Enzyme Inhibitors [D27.505.519.389.745.085]
Antihypertensive Agents [D27.505.954.411.162]
Aged [M01.060.116.100]
Anti-Inflammatory Agents, Non-Steroidal [D27.505.696.663.850.014.040.500]
Arthritis [C05.550.114]
Atherosclerosis [C14.907.137.126.307]
Blood Pressure [G09.330.380.076]
Edema [C23.888.277]
Essential Hypertension [C14.907.489.165]
Heart Failure [C14.280.434]
Hemodynamics [G09.330.380]
Homeostasis [G07.410]
Hyperkalemia [C18.452.950.396]
Hypertension [C14.907.489]
Kidney Diseases [C13.351.968.419]
Renal Artery Obstruction [C13.351.968.419.775]
Renin-Angiotensin System [G03.820]
Smoking [F01.145.466.753]
